Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: A meta-analysis

Journal of Child Neurology

Volumn 14, Issue 9, 1999, Pages 602-609

  Gilbert, Donald L ^a,b   Gartside, Peter S ^a   Glauser, Tracy A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; ISOFLURANE; MIDAZOLAM; PENTOBARBITAL; THIOPENTAL;

ADOLESCENT; ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DRUG EFFECT; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEMALE; GRAND MAL SEIZURE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL;

EID: 0032875476     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389901400909     Document Type: Article

References (31)

1. Anonymous: Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus, comments. JAMA 1993;270:854-859.
2. Singhi S, Banerjee S, Singhi P: Refractory status epilepticus in children: Role of continuous diazepam infusion. J Child Neurol 1998; 13:23-26.
3. Bertz RJ, Howrie DL: Diazepam by continuous intravenous infusion for status epilepticus in anticonvulsant hypersensitivity syndrome. Ann Pharmacother 1993;27:298-301.
4. Goitein KJ, Mussaffi H, Melamed E: Treatment of status epilepticus with thiopentone sodium anaesthesia in a child. Eur J Pediatr 1983;140:133-135.
5. Kofke WA, Young RS, Davis P, et al: Isoflurane for refractory status epilepticus: A clinical series. Anesthesiology 1989;71:653-659.
6. Crawford TO, Mitchell WG, Snodgrass SR: Lorazepam in childhood status epilepticus and serial seizures: Effectiveness and tachyphylaxis. Neurology 1987;37:190-195.
7. Kumar A, Bleck TP: Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992;20:483-488.
8. Lal Koul R, Raj AG, Chacko A, et al: Continuous midazolam infusion as treatment of status epilepticus. Arch Dis Child 1997;76: 445-448.
9. Parent JM, Lowenstein DH: Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology 1994;44:1837-1840.
10. Rivera R, Segnini M, Baltodano A, Pérez V: Midazolam in the treatment of status epilepticus in children, comments. Crit Care Med 1993;21:991-994.
11. Sheth RD, Buckley DJ, Gutierrez AR, et al: Midazolam in the treatment of refractory neonatal seizures. Clin Neuropharmacol 1996;19:165-170.
12. Kinoshita H, Nakagawa E, Iwasaki Y, et al: Pentobarbital therapy for status epilepticus in children: Timing of tapering. Pediatr Neurol 1995;13:164-168.
13. Lowenstein DH, Aminoff MJ, Simon RP: Barbiturate anesthesia in the treatment of status epilepticus: Clinical experience with 14 patients. Neurology 1988;38:395-400.
14. Rashkin MC, Youngs C, Penovich P: Pentobarbital treatment of refractory status epilepticus. Neurology 1987;37:500-503.
15. Van Ness PC: Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 1990;31:61-67.
16. Young RS, Ropper AH, Hawkes D, et al: Pentobarbital in refractory status epilepticus. Pediatr Pharmacol (New York) 1983;3: 63-67.
17. Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR: Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology 1988;38:1035-1040.
18. Exil G, Clancy RR, Hyder DJ: Propofol treatment of refractory status epilepticus: A report of five pediatric cases, abstract. Epilepsia 1995;36:124.
19. Eriksson KJ, Koivikko MJ: Status epilepticus in children: Aetiology, treatment, and outcome, comments. Dev Med Child Neurol 1997;39:652-658.
20. Orlowski JP, Erenberg G, Lueders H, Cruse RP: Hypothermia and barbiturate coma for refractory status epilepticus. Crit Care Med. 1984;12:367-372.
21. Tasker RC, Boyd SG, Harden A, Matthew DJ: EEG monitoring of prolonged thiopentone administration for intractable seizures and status epilepticus in infants and young children. Neuropediatrics 1989;20:147-153.
22. Lowenstein DH, Alldredge BK: Status epilepticus. N Engl J Med 1998;338:970-976.
23. Bleck TP: Advances in the management of refractory status epilepticus, editorial. Crit Care Med 1993;21:955-957.
24. Pellock JM: Use of midazolam for refractory status epilepticus in pediatric patients. J Child Neurol 1998;13:581-587.
25. Maytal J, Shinnar S, Moshé SL, Alvarez LA: Low morbidity and mortality of status epilepticus in children. Pediatrics 1989;83:323-331.
26. Verity CM, Ross EM, Golding J: Outcome of childhood status epilepticus and lengthy febrile convulsions: Findings of national cohort study. BMJ 1993;307:225-228.
27. Labar DR, Ali A, Root J: High-dose intravenous lorazepam for the treatment of refractory status epilepticus. Neurology 1994;44: 1400-1403.
28. Motamedi GK, Noebels JL: Management of status epilepticus. Resident Staff Physician 1998;SS:S12-S19
29. Stecker MM, Kramer TH, Raps EC, et al: Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings. Epilepsia 1998;39:18-26.
30. Lacroix J, Deal C, Gauthier M, et al: Admissions to a pediatric intensive care unit for status epilepticus: A 10-year experience. Crit Care Med 1994;22:827-832.
31. LeLorier J, Gregoire G, Benhaddad A, et al: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-542.